Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular Dysfunction

Pediatric Cardiology
Michael A McCullochCarol A Wittlieb-Weber

Abstract

Duchenne muscular dystrophy (DMD) is characterized by myocardial fibrosis and left ventricular (LV) dysfunction. Implantable cardioverter defibrillator (ICD) use has not been characterized in this population but is considered for symptomatic patients with severe LV dysfunction (SLVD) receiving guideline-directed medical therapy (GDMT). We evaluated ICD utilization and efficacy in patients with DMD. Retrospective cohort study of DMD patients from 17 centers across North America between January 2, 2005 and December 31, 2015. ICD use and its effect on survival were evaluated in patients with SLVD defined as ejection fraction (EF) < 35% and/ or shortening fraction (SF) < 16% on final echocardiogram. SLVD was present in 57/436 (13.1%) patients, of which 12 (21.1%) died during the study period. Of these 12, (mean EF 20.9 ± 6.2% and SF 13.7 ± 7.2%), 8 received GDMT, 5 received steroids, and none received an ICD. ICDs were placed in 9/57 (15.8%) patients with SLVD (mean EF 31.2 ± 8.5% and SF 10.3 ± 4.9%) at a mean age of 20.4 ± 6.3 years; 8/9 received GDMT, 7 received steroids, and all were alive at study end; mean ICD duration was 36.1 ± 26.2 months. Nine ICDs were implanted at six different institutions, associated with two appropria...Continue Reading

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Mar 1, 1990·International Journal of Cardiology·G NigroR J Bain
Jun 2, 2001·The New England Journal of Medicine·M PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival Study Group
Mar 14, 2003·The American Journal of Cardiology·Candice K SilversidesDouglas W Biggar
May 21, 2004·The New England Journal of Medicine·Alan KadishUNKNOWN Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
Dec 16, 2004·JAMA : the Journal of the American Medical Association·Akshay S DesaiKenneth L Baughman
Mar 16, 2005·Journal of the American College of Cardiology·Denis DubocHenri-Marc Bécane
Jul 2, 2005·Pediatric Cardiology·L W MarkhamL H Cripe
Apr 24, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Edward K RheeDavid C Naftel
Apr 26, 2008·Journal of the American College of Cardiology·Charles I BerulRichard A Friedman
Oct 30, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Roland S WuPradeep P A Mammen
Nov 28, 2009·Heart Failure Reviews·Abdallah FayssoilDjillali Annane
Sep 6, 2012·Journal of Developmental and Behavioral Pediatrics : JDBP·Gail GellerCynda H Rushton
Jan 29, 2013·Journal of the American College of Cardiology·Gernot SchramPaul Khairy
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Jul 24, 2013·Annals of Physical and Rehabilitation Medicine·P KienyB Perrouin Verbe
Mar 1, 2014·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Thomas D RyanDavid L S Morales
May 30, 2015·Journal of the American College of Cardiology·Tara BharuchaUNKNOWN NACCS (National Australian Childhood Cardiomyopathy Study) Investigators
Aug 8, 2015·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Iqbal El-AssaadPeter F Aziz
Feb 24, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Osamu SeguchiTakeshi Nakatani
May 28, 2016·Journal of the American College of Cardiology·Forum Kamdar, Daniel J Garry
Dec 8, 2016·JAMA Cardiology·Marly Conceição SilvaCarlos Eduardo Rochitte

❮ Previous
Next ❯

Citations

Sep 29, 2020·Expert Review of Cardiovascular Therapy·Fabio de SouzaAna Paula Nucera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.